Phosphoglycolipid and methods for its use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6013640
SERIAL NO

09138305

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns a novel phosphoglycolipid compound. The compound of the subject invention is 2-Deoxy-6-O-[2-deoxy-4-O-phosphono-3-O-[(R)-3-tetradecanoyloxytetradecanoyl]-2-[(R)-3-octadecanoyloxytetradecanoylamino]-.beta.-D-glucopyranosyl]-2-[(R)-3-hexadecanoyloxytetradecanoylamino]-D-glucopyranose and pharmaceutically acceptable salts thereof. The compound is not immunoreactive, not pyrogenic, not toxic but is active in ameliorating tissue damage due to ischemia/reperfusion injury. Methods for using the subject compound to protect against reversible and irreversible damage due to ischemia/reperfusion injury are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • RIBI IMMUNOCHEM RESEARCH, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Elliott, Gary T Stevensville, MT 27 264
Sowell, C Gregory Hamilton, MT 38 1909
Weber, Patricia A Hamilton, MT 6 75

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation